Epidemiology of basal and cutaneous squamous cell carcinoma in the U.K. 2013–15: a cohort study

British Journal of Dermatology

Volumn 181, Issue 3, 2019, Pages 474-482

  Venables, Z C ^a,b,c   Nijsten, T ^d   Wong, K F ^b   Autier, P ^e   Broggio, J ^b   Deas, A ^f   Harwood, C A ^c   Hollestein, L M ^d   Langan, S M ^g   Morgan, E ^h   Proby, C M ⁱ   Rashbass, J ^b   Leigh, I M ^c  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^f INFORMATION SERVICES DIVISION   (United Kingdom)

^g ST THOMAS HOSPITAL   (United Kingdom)

^h Northern Ireland Cancer Registry   (United Kingdom)

ⁱ UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COHORT ANALYSIS; ENGLAND; FEMALE; HUMAN; KERATINOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NORTHERN IRELAND; PRIORITY JOURNAL; SCOTLAND; SKIN CARCINOMA; VERY ELDERLY; WALES; COST OF ILLNESS; INCIDENCE; PROSPECTIVE STUDY; REGISTER; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; SURVIVAL ANALYSIS; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; COST OF ILLNESS; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS; UNITED KINGDOM;

EID: 85065342839     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.17873     Document Type: Article

References (36)

1. Trakatelli M, Ulrich C, del Marmol V et al. Epidemiology of nonmelanoma skin cancer (NMSC) in Europe: accurate and comparable data are needed for effective public health monitoring and interventions. Br J Dermatol 2007; 156 (Suppl. 3):1–7.
2. Diepgen TL, Mahler V. The epidemiology of skin cancer. Br J Dermatol 2002; 146 (Suppl. 61):1–6.
3. Lansbury L, Leonardi-Bee J, Perkins W et al. Interventions for non-metastatic squamous cell carcinoma of the skin. Cochrane Database Syst Rev 2010; 4:CD007869.
4. Hollestein LM, de Vries E, Nijsten T. Trends of cutaneous squamous cell carcinoma in the Netherlands: increased incidence rates, but stable relative survival and mortality 1989–2008. Eur J Cancer 2012; 48:2046–53.
5. Holterhues C, Vries Ed, Louwman MW et al. Incidence and trends of cutaneous malignancies in the Netherlands, 1989–2005. J Invest Dermatol 2010; 130:1807–12.
6. Lomas A, Leonardi-Bee J, Bath-Hextall F. A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 2012; 166:1069–80.
7. Nijsten T, Leigh IM. Keratinocyte skin cancers in the spotlight. Br J Dermatol 2017; 177:334–5.
8. Verkouteren JAC, Ramdas KHR, Wakkee M, Nijsten T. Epidemiology of basal cell carcinoma: scholarly review. Br J Dermatol 2017; 177:359–72.
9. Green AC, Olsen CM. Cutaneous squamous cell carcinoma: an epidemiological review. Br J Dermatol 2017; 177:373–81.
10. de Vries E, Micallef R, Brewster DH et al.; EPIDERM Group. Population-based estimates of the occurrence of multiple vs first primary basal cell carcinomas in 4 European regions. Arch Dermatol 2012; 148:347–54.
11. Reinau D, Surber C, Jick SS, Meier CR. Epidemiology of basal cell carcinoma in the United Kingdom: incidence, lifestyle factors, and comorbidities. Br J Cancer 2014; 111:203–6.
12. Carsin AE, Sharp L, Comber H. Geographical, urban/rural and socioeconomic variations in nonmelanoma skin cancer incidence: a population-based study in Ireland. Br J Dermatol 2011; 164:822–9.
13. Goon PKC, Greenberg DC, Igali L, Levell NJ. Predicted cases of U.K. skin squamous cell carcinoma and basal cell carcinoma in 2020 and 2025: horizon planning for National Health Service dermatology and dermatopathology. Br J Dermatol 2017; 176:1351–3.
14. Levell NJ, Igali L, Wright KA, Greenberg DC. Basal cell carcinoma epidemiology in the UK: the elephant in the room. Clin Exp Dermatol 2013; 38:367–9.
15. Vallejo-Torres L, Morris S, Kinge JM et al. Measuring current and future cost of skin cancer in England. J Public Health (Oxf) 2014; 36:140–8.
16. Healy E, Brown SJ, Langan SM et al. Identification of translational dermatology research priorities in the U.K.: results of an electronic Delphi exercise. Br J Dermatol 2015; 173:1191–8.
17. UKIACR, Coding and Classification Group (CCG). The practise on coding and classification policy and practice agreed by the CCG. Training document: created 2 March 1999; updated June 2005. London: Public Health England, 1999 and 2005. Last accessed 19 June 2018 Available at: https://www.mylearningspace.me.uk/moodle/pluginfile.php/8354/mod_resource/content/2/The-Practise.pdf (last accessed 19 June 2018).
18. Bielsa I, Soria X, Esteve M, Ferrándiz C; Skin Cancer Study Group of Barcelonès Nord. Population-based incidence of basal cell carcinoma in a Spanish Mediterranean area. Br J Dermatol 2009; 161:1341–6.
19. Marcil I, Stern RS. Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. Arch Dermatol 2000; 136:1524–30.
20. Flohil SC, de Vries E, Neumann HA et al. Incidence, prevalence and future trends of primary basal cell carcinoma in the Netherlands. Acta Derm Venereol 2011; 91:24–30.
21. Flohil SC, van der Leest RJ, Arends LR et al. Risk of subsequent cutaneous malignancy in patients with prior keratinocyte carcinoma: a systematic review and meta-analysis. Eur J Cancer 2013; 49:2365–75.
22. Lucke TW, Hole DJ, Mackie RM. An audit of the completeness of non-melanoma skin cancer registration in Greater Glasgow. Br J Dermatol 1997; 137:761–3.
23. Poirier V. The Role of the South West Public Health Observatory as the Lead Cancer Registry for Skin Cancer (poster presentation). Presented at the British Association Dermatologist's Non-Melanoma Skin Cancer Conference, London, 2013.
24. Pandeya N, Olsen CM, Whiteman DC. The incidence and multiplicity rates of keratinocyte cancers in Australia. Med J Aust 2017; 207:339–43.
25. Department for Communities and Local Government. Index of Multiple Deprivation 2015. London: Ministry of Housing, Communities & Local Government, 2015. Available at: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2015 (last accessed 27 April 2019).
26. Office of National Statistics. Cancer Registration Statistics, England: 2015. London: ONS, 2017 (23 May 2017); Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/datasets/cancerregistrationstatisticscancerregistrationstatisticsengland (last accessed 27 April 2019).
27. Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004; 40:2307–16.
28. London School of Hygiene and Tropical Medicine. Life tables. Available at: http://csg.lshtm.ac.uk/tools-analysis/uk-life-tables/ (last accessed 27 April 2019).
29. Leigh IM. Progress in skin cancer: the U.K. experience. Br J Dermatol 2014; 171:443–5.
30. Dawson H, Serra S. Tumours and inflammatory lesions of the anal canal and perianal skin revisited: an update and practical approach. J Clin Pathol 2015; 68:971–81.
31. Public Health Agency. Skin Cancer Prevention. Belfast: PHA, n.d. Available at: http://www.publichealth.hscni.net/directorate-public-health/health-and-social-wellbeing-improvement/skin-cancer-prevention (last accessed 27 April 2019).
32. Public Health Agency. Care in the Sun: Outdoor Work, Sports and Leisure. Belfast: Cancer Focus Northern Ireland, n.d. Available at: https://careinthesun.org/sun-protection/outdoor-work-sports-and-leisure/ (last accessed 27 April 2019).
33. Doherty VR, Brewster DH, Jensen S, Gorman D. Trends in skin cancer incidence by socioeconomic position in Scotland, 1978–2004. Br J Cancer 2010; 102:1661–4.
34. Office of National Statistics. Ethnicity and National Identity in England and Wales: 2011. London: ONS, 2012. Available at: https://www.ons.gov.uk/peoplepopulationandcommunity/culturalidentity/ethnicity/articles/ethnicityandnationalidentityinenglandandwales/2012-12-11 (last accessed 27 April 2019).
35. Venables ZC, Autier P, Nijsten T et al. Nationwide incidence of metastatic cutaneous squamous cell carcinoma in England. JAMA Dermatol 2019; 155:298–306.
36. Eisemann N, Jansen L, Castro FA et al.; GEKID Cancer Survival Working Group. Survival with nonmelanoma skin cancer in Germany. Br J Dermatol 2016; 174:778–85.